Gastric Cancer

Study 1 Description

Phase II trial of docetaxel plus oxaliplatin (DOCOX) with or without cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma.

For additional information about Highline's Cancer Care Program, call (206) 439-5577.